PubMed

Updated fracture incidence rates for the US version of FRAX.

Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ 3rd.

Osteoporos Int. 2010 Jan;21(1):25-33. Epub 2009 Aug 25.PMID: 19705048 [PubMed - in process]Related articlesFree article

FRAX facts.

Watts NB, Ettinger B, LeBoff MS.

J Bone Miner Res. 2009 Jun;24(6):975-9. No abstract available. PMID: 19364271 [PubMed - indexed for MEDLINE]Related articles

Questioning the accuracy of a recent review of osteoporosis medications.

Kuhl LN, Ettinger B, Rosen CJ, Col NF.

Ann Intern Med. 2009 Mar 17;150(6):423-4; author reply 424-5. No abstract available. PMID: 19293078 [PubMed - indexed for MEDLINE]Related articlesFree article

Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach.

Ettinger B, Hait H, Reape KZ, Shu H.

Menopause. 2008 Sep-Oct;15(5):885-9.PMID: 18779677 [PubMed - indexed for MEDLINE]Related articles

Endometrial effects of tibolone in elderly, osteoporotic women.

Ettinger B, Kenemans P, Johnson SR, Mol-Arts M, Van Os S, Seifert W, Verweij PJ, Cummings SR.

Obstet Gynecol. 2008 Sep;112(3):653-9.PMID: 18757665 [PubMed - indexed for MEDLINE]Related articles

A personal perspective on fracture risk assessment tools.

Ettinger B.

Menopause. 2008 Sep-Oct;15(5):1023-6.PMID: 18703988 [PubMed - indexed for MEDLINE]Related articles

The effects of tibolone in older postmenopausal women.

Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R; LIFT Trial Investigators.

N Engl J Med. 2008 Aug 14;359(7):697-708.PMID: 18703472 [PubMed - indexed for MEDLINE]Related articlesFree article

Appropriate intervention through fracture risk assessment.

Ettinger B.

Manag Care. 2005 Aug;14(8 Suppl Osteoporosis):9-12; discussion 21-3. No abstract available. PMID: 18564556 [PubMed - indexed for MEDLINE]Related articles

Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo JC, Johnston JM, Cauley JA, Danielson ME, Neer RM.

J Clin Endocrinol Metab. 2008 Mar;93(3):861-8. Epub 2007 Dec 26.PMID: 18160467 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.

Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H.

Curr Med Res Opin. 2007 Oct;23(10):2517-29.PMID: 17825128 [PubMed - indexed for MEDLINE]Related articles

Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women.

Huang AJ, Ettinger B, Vittinghoff E, Ensrud KE, Johnson KC, Cummings SR.

J Bone Miner Res. 2007 Nov;22(11):1791-7.PMID: 17620054 [PubMed - indexed for MEDLINE]Related articles

Rationale for use of lower estrogen doses for postmenopausal hormone therapy.

Ettinger B.

Maturitas. 2007 May 20;57(1):81-4. Epub 2007 Mar 23. Review.PMID: 17383126 [PubMed - indexed for MEDLINE]Related articles

Tibolone for prevention and treatment of postmenopausal osteoporosis.

Ettinger B.

Maturitas. 2007 May 20;57(1):35-8. Epub 2007 Mar 12. Review.PMID: 17350774 [PubMed - indexed for MEDLINE]Related articles

High-dose corticosteroid exposure and osteoporosis intervention in adults.

Che M, Ettinger B, Nguyen MT, Pressman AR, Johnston J.

Ann Allergy Asthma Immunol. 2006 Oct;97(4):497-501.PMID: 17069105 [PubMed - indexed for MEDLINE]Related articles

Comparison of methods to measure low serum estradiol levels in postmenopausal women.

Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D, Cummings SR.

J Clin Endocrinol Metab. 2006 Oct;91(10):3791-7. Epub 2006 Aug 1.PMID: 16882749 [PubMed - indexed for MEDLINE]Related articlesFree article

When is it appropriate to prescribe postmenopausal hormone therapy?

Ettinger B, Barrett-Connor E, Hoq LA, Vader JP, Dubois RW.

Menopause. 2006 May-Jun;13(3):404-10.PMID: 16735937 [PubMed - indexed for MEDLINE]Related articles

Persistence with weekly alendronate therapy among postmenopausal women.

Lo JC, Pressman AR, Omar MA, Ettinger B.

Osteoporos Int. 2006;17(6):922-8. Epub 2006 Apr 12.PMID: 16609824 [PubMed - indexed for MEDLINE]Related articles

Outcomes of a disease-management program for patients with recent osteoporotic fracture.

Che M, Ettinger B, Liang J, Pressman AR, Johnston J.

Osteoporos Int. 2006;17(6):847-54. Epub 2006 Mar 29.PMID: 16570119 [PubMed - indexed for MEDLINE]Related articles

The Classic: Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. 1982.

Genant HK, Cann CE, Ettinger B, Gordan GS.

Clin Orthop Relat Res. 2006 Feb;443:14-8. No abstract available. PMID: 16462420 [PubMed - indexed for MEDLINE]Related articles

Vasomotor symptom relief versus unwanted effects: role of estrogen dosage.

Ettinger B.

Am J Med. 2005 Dec 19;118 Suppl 12B:74-8.PMID: 16414330 [PubMed - indexed for MEDLINE]Related articles

Making the most of managed care dollars spent for postmenopausal osteoporosis.

Ettinger B.

Manag Care Interface. 2005 Dec;18(12):55-9.PMID: 16405226 [PubMed - indexed for MEDLINE]Related articles

Hormone predictors of bone mineral density changes during the menopausal transition.

Sowers MR, Jannausch M, McConnell D, Little R, Greendale GA, Finkelstein JS, Neer RM, Johnston J, Ettinger B.

J Clin Endocrinol Metab. 2006 Apr;91(4):1261-7. Epub 2006 Jan 10.PMID: 16403818 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of raloxifene among women with a history of breast cancer.

Habel LA, Pressman A, Ettinger B, Sidney S, Suh-Burgmann B, Fehrenbacher L, Quesenberry CP.

Breast Cancer Res Treat. 2006 Mar;96(2):123-9.PMID: 16319985 [PubMed - indexed for MEDLINE]Related articles

Bisphosphonates: providing strength to a significant class.

Ettinger B.

Manag Care. 2005 May;14(5 Suppl):24-8. No abstract available. PMID: 15962834 [PubMed - indexed for MEDLINE]Related articles

Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.

Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D.

Obstet Gynecol. 2005 Apr;105(4):779-87.PMID: 15802405 [PubMed - indexed for MEDLINE]Related articles

Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women.

Ettinger B, Hillier TA, Pressman A, Che M, Hanley DA.

J Womens Health (Larchmt). 2005 Mar;14(2):159-71.PMID: 15775734 [PubMed - indexed for MEDLINE]Related articles

Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.

Grady D, Ettinger B, Moscarelli E, Plouffe L Jr, Sarkar S, Ciaccia A, Cummings S; Multiple Outcomes of Raloxifene Evaluation Investigators.

Obstet Gynecol. 2004 Oct;104(4):837-44.PMID: 15458908 [PubMed - indexed for MEDLINE]Related articles

Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.

Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, Vittinghoff E, Grady D.

Obstet Gynecol. 2004 Sep;104(3):443-51.PMID: 15339752 [PubMed - indexed for MEDLINE]Related articles

Effect of isoflavones on lipids and bone turnover markers in menopausal women.

Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA.

Maturitas. 2004 Jul 15;48(3):209-18.PMID: 15207886 [PubMed - indexed for MEDLINE]Related articles

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.

Ettinger B, San Martin J, Crans G, Pavo I.

J Bone Miner Res. 2004 May;19(5):745-51. Epub 2004 Jan 19.PMID: 15068497 [PubMed - indexed for MEDLINE]Related articles

Limb fractures in elderly men as indicators of subsequent fracture risk.

Ettinger B, Ray GT, Pressman AR, Gluck O.

Arch Intern Med. 2003 Dec 8-22;163(22):2741-7.PMID: 14662628 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of difficulty when discontinuing postmenopausal hormone therapy.

Grady D, Ettinger B, Tosteson AN, Pressman A, Macer JL.

Obstet Gynecol. 2003 Dec;102(6):1233-9.PMID: 14662209 [PubMed - indexed for MEDLINE]Related articles

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL.

Obstet Gynecol. 2003 Dec;102(6):1225-32.PMID: 14662208 [PubMed - indexed for MEDLINE]Related articles

Early discontinuation of treatment for osteoporosis.

Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B.

Am J Med. 2003 Aug 15;115(3):209-16.PMID: 12947959 [PubMed - indexed for MEDLINE]Related articles

Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.

Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR.

JAMA. 2003 Jul 9;290(2):207-14.PMID: 12851275 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk for fracture in women with low serum levels of thyroid-stimulating hormone.

Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group.

Ann Intern Med. 2001 Apr 3;134(7):561-8.PMID: 12803168 [PubMed - indexed for MEDLINE]Related articlesFree article

Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.

Sowers MR, Greendale GA, Bondarenko I, Finkelstein JS, Cauley JA, Neer RM, Ettinger B.

Osteoporos Int. 2003 May;14(3):191-7. Epub 2003 Apr 11.PMID: 12730778 [PubMed - indexed for MEDLINE]Related articles

Thyroid hormone use and the risk of hip fracture in women > or = 65 years: a case-control study.

Van Den Eeden SK, Barzilay JI, Ettinger B, Minkoff J.

J Womens Health (Larchmt). 2003 Jan-Feb;12(1):27-31.PMID: 12639366 [PubMed - indexed for MEDLINE]Related articles

The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.

Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley JA, Sherman S, Greendale GA; Study of Women's Health Across the Nation.

Osteoporos Int. 2003 Jan;14(1):44-52.PMID: 12577184 [PubMed - indexed for MEDLINE]Related articles

Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults.

Cobb KL, Kelsey JL, Sidney S, Ettinger B, Lewis CE.

Osteoporos Int. 2002 Nov;13(11):893-900.PMID: 12415437 [PubMed - indexed for MEDLINE]Related articles

Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors.

Finkelstein JS, Lee ML, Sowers M, Ettinger B, Neer RM, Kelsey JL, Cauley JA, Huang MH, Greendale GA.

J Clin Endocrinol Metab. 2002 Jul;87(7):3057-67.PMID: 12107201 [PubMed - indexed for MEDLINE]Related articlesFree article

Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors.

Finkelstein JS, Sowers M, Greendale GA, Lee ML, Neer RM, Cauley JA, Ettinger B.

J Clin Endocrinol Metab. 2002 Jul;87(7):3051-6.PMID: 12107200 [PubMed - indexed for MEDLINE]Related articlesFree article

Gastric and duodenal safety of daily alendronate.

Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, Buist DS, Carey VJ, Chandler JM, Chase GA, Ettinger B, Fishman P, Goodman M, Guess HA, Gurwitz JH, LaCroix AZ, Levin TR, Platt R.

Arch Intern Med. 2002 Apr 22;162(8):936-42.PMID: 11966346 [PubMed - indexed for MEDLINE]Related articlesFree article

For osteoporosis, are two antiresorptive drugs better than one?

Ettinger B, Bilezikian JP.

J Clin Endocrinol Metab. 2002 Mar;87(3):983-4. No abstract available. PMID: 11889148 [PubMed - indexed for MEDLINE]Related articlesFree article

Timing of estrogen replacement therapy for optimal osteoporosis prevention.

Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B; Study of Osteoporotic Fractures Research Group.

J Clin Endocrinol Metab. 2001 Dec;86(12):5700-5.PMID: 11739424 [PubMed - indexed for MEDLINE]Related articlesFree article

Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy.

Figueroa-Casas PR, Ettinger B, Delgado E, Javkin A, Vieder C.

Menopause. 2001 Nov-Dec;8(6):420-3. Review.PMID: 11723414 [PubMed - indexed for MEDLINE]Related articles

Postmenopausal hormonal support: discontinuation of raloxifene versus estrogen.

Kayser J, Ettinger B, Pressman A.

Menopause. 2001 Sep-Oct;8(5):328-32.PMID: 11528358 [PubMed - indexed for MEDLINE]Related articles

Low-dosage esterified estrogens opposed by progestin at 6-month intervals.

Ettinger B, Pressman A, Van Gessel A.

Obstet Gynecol. 2001 Aug;98(2):205-11.PMID: 11506834 [PubMed - indexed for MEDLINE]Related articles

Initiation of osteoporosis treatment after bone mineral density testing.

Pressman A, Forsyth B, Ettinger B, Tosteson AN.

Osteoporos Int. 2001;12(5):337-42.PMID: 11444079 [PubMed - indexed for MEDLINE]Related articles

Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.

Ettinger B, Chidambaran P, Pressman A.

Am J Manag Care. 2001 Jun;7(6):597-605.PMID: 11439733 [PubMed - indexed for MEDLINE]Related articlesFree article